Dental Care Clinics in Hull, MA Accepting Medicare
6 Dental Care Clinics found. Showing 1 - 6
 Hull Family Dental Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 278 Nantasket Ave, Hull, MA 02045 Phone: 781-925-3303 Fax: 781-925-9210 |
Locke White Dental Associates Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 529 Nantasket Ave, Hull, MA 02045 Phone: 781-925-5100 Fax: 781-925-9791 |
Hull Family Dental, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 529 Nantasket Ave, Hull, MA 02045 Phone: 781-925-5100 |
Nantasket Family Dental Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 278 Nantasket Ave, Hull, MA 02045 Phone: 781-925-3303 Fax: 781-925-9210 |
Hull Dental Professional Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 278 Nantasket Ave, Hull, MA 02045 Phone: 781-925-3303 |
Maurice Lussier Dentist Medicare: Not Enrolled in Medicare Practice Location: 278 Nantasket Ave, Hull, MA 02045 Phone: 781-925-3303 Fax: 781-925-9210 |
News Archive
SBFA partners with Hema-Quebec to provide strong support for blood safety and donor programs in Africa
Safe Blood for Africa Foundation (SBFA) and Hema-Quebec have announced the signing of a formal joint agreement to provide even stronger support for blood safety and donor programs in Africa.
Scientists discover promising new therapeutic target for heart disease
Scientists at the Boston Biomedical Research Institute identified Puma (p53 upregulated modulator of apoptosis) as a potential new target for the therapeutic intervention of heart disease.
Springer and BMES to publish 'Cardiovascular Engineering and Technology' journal
Springer and the Biomedical Engineering Society (BMES) have founded a new journal Cardiovascular Engineering and Technology (CVET). CVET is a forum for research on all aspects of cardiovascular physiology and medical treatment.
NHS could save 2 billion pounds by switching to generic cholesterol lowering drugs
The NHS in England could save over £2bn in the next five years if doctors simply switched patients to cheaper generic cholesterol lowering drugs (statins), say two senior doctors in this week's British Medical Journal.
Novelos completes I-131-CLR1404 Phase 1b trial on advanced solid tumors
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it has successfully completed the first cohort in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound I-131-CLR1404 (HOT) in cancer patients with advanced solid tumors.
› Verified 9 days ago